DE60135846D1 - Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen - Google Patents

Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen

Info

Publication number
DE60135846D1
DE60135846D1 DE60135846T DE60135846T DE60135846D1 DE 60135846 D1 DE60135846 D1 DE 60135846D1 DE 60135846 T DE60135846 T DE 60135846T DE 60135846 T DE60135846 T DE 60135846T DE 60135846 D1 DE60135846 D1 DE 60135846D1
Authority
DE
Germany
Prior art keywords
peptides
diagnosis
cardiovascular diseases
cyclised
affinity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60135846T
Other languages
German (de)
English (en)
Inventor
Outi Narvanen
Seppo Yla-Herttuala
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ark Therapeutics Oy
Original Assignee
Ark Therapeutics Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ark Therapeutics Oy filed Critical Ark Therapeutics Oy
Application granted granted Critical
Publication of DE60135846D1 publication Critical patent/DE60135846D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60135846T 2000-07-18 2001-07-18 Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen Expired - Fee Related DE60135846D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017641.2A GB0017641D0 (en) 2000-07-18 2000-07-18 Peptides and their use
PCT/GB2001/003212 WO2002006314A2 (en) 2000-07-18 2001-07-18 Peptides and their use in assays for cardiovascular disease

Publications (1)

Publication Number Publication Date
DE60135846D1 true DE60135846D1 (de) 2008-10-30

Family

ID=9895897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135846T Expired - Fee Related DE60135846D1 (de) 2000-07-18 2001-07-18 Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen

Country Status (12)

Country Link
US (2) US20040091934A1 (enExample)
EP (1) EP1301537B1 (enExample)
JP (1) JP2004504327A (enExample)
AT (1) ATE408626T1 (enExample)
AU (1) AU2001270851A1 (enExample)
CA (1) CA2417789A1 (enExample)
DE (1) DE60135846D1 (enExample)
DK (1) DK1301537T3 (enExample)
ES (1) ES2312455T3 (enExample)
GB (1) GB0017641D0 (enExample)
PT (1) PT1301537E (enExample)
WO (1) WO2002006314A2 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
AU2002362612B2 (en) 2001-09-28 2007-11-15 Cedars-Sinai Medical Center Prevention and treatment of restenosis by local administration of drug
WO2005097206A2 (en) 2004-04-06 2005-10-20 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
US20080305512A1 (en) * 2006-10-26 2008-12-11 Mattingly Phillip G Assay for cardiac troponin autoantibodies
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
WO2008051762A2 (en) * 2006-10-26 2008-05-02 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
EP2115466A4 (en) * 2006-12-22 2010-07-28 Abbott Lab HEART CIRCUIT AUTOIMMUNE DISEASE TEST GROUP AND METHOD FOR USE THEREOF
AU2011336997A1 (en) 2010-11-12 2013-05-30 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension
WO2012065133A1 (en) 2010-11-12 2012-05-18 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
JP5857312B2 (ja) * 2011-08-11 2016-02-10 積水メディカル株式会社 心疾患診断マーカー
CN107085025B (zh) * 2016-02-15 2019-09-17 太原师范学院 一种自组装三层膜电极及其制备方法和用途
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
EP3463416A1 (en) 2016-05-31 2019-04-10 CardioVax, LLC Methods for diagnosing and treating systemic lupus erythematosus
CN111855986A (zh) * 2019-04-25 2020-10-30 常州博闻迪医药股份有限公司 联合定量检测五项心脏标志物试剂盒及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
GB9609702D0 (en) * 1996-05-09 1996-07-10 Royal Free Hosp School Med Anticoagulant peptides
GB9705831D0 (en) * 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
EP1021728B8 (en) * 1997-06-20 2008-04-23 Leuven Research & Development VZW Assays, antibodies, and standards for detection of oxidized and mda-modified low density lipoproteins

Also Published As

Publication number Publication date
US20080261234A1 (en) 2008-10-23
US20040091934A1 (en) 2004-05-13
ES2312455T3 (es) 2009-03-01
JP2004504327A (ja) 2004-02-12
EP1301537A2 (en) 2003-04-16
WO2002006314A2 (en) 2002-01-24
DK1301537T3 (da) 2008-12-08
PT1301537E (pt) 2008-12-04
EP1301537B1 (en) 2008-09-17
WO2002006314A3 (en) 2002-04-18
GB0017641D0 (en) 2000-09-06
CA2417789A1 (en) 2002-01-24
AU2001270851A1 (en) 2002-01-30
ATE408626T1 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
DE60135846D1 (de) Peptide und ihre verwendung in der diagnostik von kardiovaskulären erkrankungen
Chitte et al. Potent fibrinolytic enzyme from a thermophilic Streptomyces megasporus strain SD5
DE60323231D1 (de) Verkürzte tau proteine
DE69840107D1 (de) Glukosebiosensor
DE60322339D1 (de) Bindungsproteine als biosensoren
ATE278186T1 (de) Elektrochemischer sensor zur bestimmung der blutgerinnung, ein entsprechendes blutgerinnungsmesssystem sowie ein verfahren zur bestimmung der blutgerinnung
EP1565482A4 (en) A34 AND A33 LIKE-3 DNA, PROTEINS, ANTIBODIES, AND TREATMENT METHODS USED THEREOF
DE60026337D1 (de) Verfahren zur diagnose von leberkrankheit unter verwendung von biochemischen merkmalen
ATE526399T1 (de) Neue biologische einheiten und deren verwendung
DE60039986D1 (de) Nukleinsäureliganden von tenascin-c
EP1053315A4 (en) HUMAN 'HAARLOS' GENE AND PROTEIN AND THEIR USE
ATE432358T1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
NO20012017D0 (no) Anvendelse av VEGF-C eller VEGF-D gen eller protein for å forebygge restenose
ATE335763T1 (de) Sandwich-immunoassay zur bestimmung von proanp- teilpeptiden
Raymond et al. α2-Macroglobulin capture allows detection of mast cell chymase in serum and creates a reservoir of angiotensin II-generating activity
PT1406898E (pt) Compostos de piperazina substituida e sua utilizacao como inibidores de oxidacao de acidos gordos
NO20052992L (no) Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom.
ATE376001T1 (de) Kondensiertes protein, das sowohl thrombolytisch als auch gerinnungshemmend wirkt, und dessen verwendung
ATE342510T1 (de) Komplementierungsassay für den nachweis von protein-löslichkeit und -faltung
Tsushima et al. Candida albicans aspartic proteinase cleaves and inactivates human epidermal cysteine proteinase inhibitor, cystatin A
DE60210014D1 (de) Auf Zellen gegründetes Phosphodiesterase-10A-Assay und Sequenzen
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
ATE389029T1 (de) Protease assay zur kontrolle medikamentöser therapie
BR0308978A (pt) fragmentos de peptìdeos sintéticos ativos
DE60045932D1 (de) HIV-1-Sequenzverstärkung zur Erkennung von Sequenzen in Zusammenhang mit Wirkstoffresistenz-Mutationen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee